FDA approved the Amgen agent Vectibix (panitumumab) for use in combination with FOLFOX as first-line treatment in patients with wild-type KRAS (exon 2) metastatic colorectal cancer.
THE CENTERS FOR DISEASE CONTROL AND PREVENTION is recruiting for the position of Director of the Division of Cancer Prevention and Control in the National Center for Chronic Disease Prevention and Health Promotion.
THE MAYO CLINIC signed an agreement with N-of-One to provide access to clinical interpretation information to aid molecular diagnostics.
THE JAMES GRAHAM BROWN CANCER CENTER at the University of Louisville received a three-year, $5.5 million grant to develop new treatments and vaccines for various forms of cancer from the Leona M. and Harry B. Helmsley Charitable Trust.
MD ANDERSON CANCER CENTER signed an agreement with Concord Medical Services Holdings Limited to serve as a consultant for its cancer hospital projects under planning in Shanghai and Beijing.
THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY launched an online Resource Center to help oncologists and patients understand the Patient Information and Affordable Care Act and the law's impact on oncology practices and patients.
The Department of Defense Lung Cancer Research Program will provide $10.5 million to support innovative, high-impact lung cancer research during fiscal 2014.
SUSAN GOODIN was named executive officer of the Big Ten Cancer Research Consortium.
The Special Awards honorees at the 2014 meeting of the American Society of Clinical Oncology are:
Moffitt Cancer Center and the Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute earlier this week announced that they are constructing a bioinformatics framework that would enable a multi-center collaboration.
